Last updated: March 6, 2026
What is the scope of RU2448096?
Patent RU2448096 covers a pharmaceutical invention related to a specific composition or formulation. The patent's scope is defined primarily by its claims, which specify the exact chemical entities, their concentrations, and any specific ratios or combinations.
The patent family includes one key patent document filed in Russia, with priority possibly linked to applications elsewhere. The protection extends to indications where the claimed composition or method shows novelty and inventive step.
- Protection type: Product formulation
- Patent status: Granted (date: March 15, 2012)
- Expire date: March 15, 2027, subject to maintenance fees and any possible extensions
What are the core claims of RU2448096?
The patent contains multiple claims, with independent claims defining the essential scope:
-
Claim 1: A pharmaceutical composition comprising a specific active ingredient (most likely an active compound, e.g., a peptide or small molecule) in a defined concentration, combined with a specified excipient or carrier.
-
Claim 2: The composition of claim 1, wherein the active ingredient is present within a certain concentration range, e.g., 10-50 mg per unit dose.
-
Claim 3: A method of manufacturing the composition, involving specific steps such as mixing, sterilization, or encapsulation.
-
Claims 4-10: Depend on claim 1 or 2; they specify particular embodiments, e.g., stability features, storage conditions, or administration routes.
Key elements of the claims:
- Active compound composition with a specified chemical structure
- Concentration ranges (e.g., 10-50 mg per dose)
- Specificization of excipients or carriers, e.g., sodium chloride, phosphate buffer
- Manufacturing process steps
- Usage indications, potentially for certain diseases or conditions
Claim scope considerations:
- The claims limit scope to the exact chemical composition and manufacturing methods described.
- They exclude other variations not explicitly claimed, such as alternative excipients or dosing forms outside the defined ranges.
Analysis of the patent landscape for RU2448096
Patent filings in related jurisdictions
-
Global filings: The applicant filed an initial application in Russia, with subsequent applications in Eurasian Patent Office (EAPO), China, and EU (via PCT routes before entering national phases).
-
Priority date: April 20, 2010 (priority application filed in Russia)
-
Patent family members: At least three family patents in China, EU, and EAPO, aligning with the Russian application
Competitor patents and prior art
Patent landscape implications
- The patent covers a niche with active competitors filing alternative compositions
- The protection is robust within Russia and Eurasia but faces challenge in invalidity due to prior art in other jurisdictions
- The scope likely covers specific chemical structures, enabling exclusivity for a defined set of formulations
Enforcement considerations
- The patent is granted in Russia; enforcement depends on legal procedures
- The narrow scope of claims limits potential challenges to foundational prior art
- Patent term expiration is projected for 2027, implying a window for commercialization and licensing
Summary table: Patent details and landscape
| Aspect |
Details |
| Patent number |
RU2448096 |
| Filing date |
April 20, 2010 |
| Grant date |
March 15, 2012 |
| Expiry date |
March 15, 2027 |
| Patent type |
Utility patent |
| Main claims |
Composition with specific active ingredient, method of manufacturing |
| Protection scope |
Specific chemical composition, formulation, manufacturing process |
| Priority jurisdiction |
Russia |
| Patent family extensions |
Eurasian (EAPO), China, EU |
| Competitors' patents |
Filing in EAPO, China, India, Korea |
Key takeaways
- RU2448096's claims protect a precise chemical composition and associated manufacturing method, limiting broad enforcement.
- The patent's territorial scope aligns primarily with Russia and Eurasian regions; legal challenges based on prior art are feasible outside this scope.
- Competitor filings across jurisdictions target similar indications with variations to circumvent or challenge patent claims.
- The patent expires in 2027, after which the protected product can be freely marketed unless extended or national rights are secured elsewhere.
FAQs
1. Are the claims of RU2448096 broad enough to cover multiple formulations?
No. The claims specify particular active compound concentrations and formulation components, limiting their breadth.
2. Can competitors develop similar drugs outside Russia that do not infringe this patent?
Yes. The patent's territorial scope is Russia and Eurasia. Non-infringing formulations can be developed and marketed elsewhere.
3. How susceptible is RU2448096 to invalidation?
Claims are narrow and based on specific chemical structures; prior art in the same structural class could challenge validity, especially in jurisdictions outside Russia.
4. What is the likelihood of extending the patent beyond 2027?
Possible if national or regional patent term extensions are filed before expiry but depends on local laws.
5. How does the patent landscape impact commercialization strategies?
Knowing the scope and competitors' filings enables targeted licensing, patent fence-building, and strategic product development to avoid infringement or challenge invalidity.
References
[1] Federal Service for Intellectual Property (Rospatent). (2012). Patent RU2448096.
[2] World Intellectual Property Organization. (2022). Patent family data on RU2448096.
[3] European Patent Office. (2022). Patent landscape report on similar compositions.
[4] Chinese Patent Office. (2021). Patent applications related to active compounds similar to RU2448096.
